Class information for:
Level 1: MONTELUKAST//LEUKOTRIENE RECEPTOR ANTAGONIST//CYSTEINYL LEUKOTRIENES

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
6315 1501 39.5 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
275 3       NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 43399
566 2             EPOXYEICOSATRIENOIC ACIDS//LIPOXYGENASE//LEUKOTRIENES 14430
6315 1                   MONTELUKAST//LEUKOTRIENE RECEPTOR ANTAGONIST//CYSTEINYL LEUKOTRIENES 1501

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MONTELUKAST authKW 2349999 18% 43% 267
2 LEUKOTRIENE RECEPTOR ANTAGONIST authKW 1238005 9% 45% 134
3 CYSTEINYL LEUKOTRIENES authKW 866472 8% 36% 120
4 PRANLUKAST authKW 858920 4% 66% 64
5 ZAFIRLUKAST authKW 665672 4% 55% 60
6 MONTELUKAST SODIUM authKW 361666 2% 66% 27
7 LEUKOTRIENES authKW 304006 11% 9% 166
8 CYSTEINYL LEUKOTRIENE RECEPTOR 1 authKW 234522 1% 82% 14
9 LEUKOTRIENE ANTAGONISTS authKW 230095 2% 31% 37
10 CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST authKW 219675 1% 60% 18

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Allergy 35121 23% 1% 340
2 Respiratory System 11591 23% 0% 347
3 Immunology 3330 24% 0% 355
4 Pharmacology & Pharmacy 2158 24% 0% 357
5 Critical Care Medicine 1593 7% 0% 100
6 Medicine, General & Internal 304 8% 0% 123
7 Pediatrics 116 4% 0% 61
8 Cell Biology 105 6% 0% 96
9 Chemistry, Medicinal 69 3% 0% 42
10 Medicine, Research & Experimental 68 4% 0% 56

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SECT EICOSANOID PHARMACOL 63564 0% 63% 5
2 PULM IMMUNOL 62305 1% 26% 12
3 MOL CELLULAR PHARMACOL PURINERG TRANSMISS 40173 1% 22% 9
4 MED MC6076 30509 0% 50% 3
5 ALLERGOL IMMUNOL POLICLIN 20342 0% 100% 1
6 ALLERGY CLIN IMMUNOL PULM 20342 0% 100% 1
7 ALLERGYPEDIAT CLIN 2 20342 0% 100% 1
8 ALLIED DHQ HOSP 20342 0% 100% 1
9 ASHKELON AFFILIATED MED 20342 0% 100% 1
10 ASTHMA ALLERGY P SCIGUYS HOSP 20342 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 15851 6% 1% 91
2 CLINICAL AND EXPERIMENTAL ALLERGY 10001 3% 1% 50
3 PULMONARY PHARMACOLOGY & THERAPEUTICS 9278 2% 2% 26
4 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 7761 4% 1% 61
5 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 7605 2% 1% 37
6 JOURNAL OF ASTHMA 3866 2% 1% 24
7 AMERICAN REVIEW OF RESPIRATORY DISEASE 3546 2% 1% 33
8 PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS 2323 1% 1% 19
9 THORAX 2207 2% 0% 28
10 ALLERGY AND ASTHMA PROCEEDINGS 2154 1% 1% 13

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 MONTELUKAST 2349999 18% 43% 267 Search MONTELUKAST Search MONTELUKAST
2 LEUKOTRIENE RECEPTOR ANTAGONIST 1238005 9% 45% 134 Search LEUKOTRIENE+RECEPTOR+ANTAGONIST Search LEUKOTRIENE+RECEPTOR+ANTAGONIST
3 CYSTEINYL LEUKOTRIENES 866472 8% 36% 120 Search CYSTEINYL+LEUKOTRIENES Search CYSTEINYL+LEUKOTRIENES
4 PRANLUKAST 858920 4% 66% 64 Search PRANLUKAST Search PRANLUKAST
5 ZAFIRLUKAST 665672 4% 55% 60 Search ZAFIRLUKAST Search ZAFIRLUKAST
6 MONTELUKAST SODIUM 361666 2% 66% 27 Search MONTELUKAST+SODIUM Search MONTELUKAST+SODIUM
7 LEUKOTRIENES 304006 11% 9% 166 Search LEUKOTRIENES Search LEUKOTRIENES
8 CYSTEINYL LEUKOTRIENE RECEPTOR 1 234522 1% 82% 14 Search CYSTEINYL+LEUKOTRIENE+RECEPTOR+1 Search CYSTEINYL+LEUKOTRIENE+RECEPTOR+1
9 LEUKOTRIENE ANTAGONISTS 230095 2% 31% 37 Search LEUKOTRIENE+ANTAGONISTS Search LEUKOTRIENE+ANTAGONISTS
10 CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST 219675 1% 60% 18 Search CYSTEINYL+LEUKOTRIENE+RECEPTOR+ANTAGONIST Search CYSTEINYL+LEUKOTRIENE+RECEPTOR+ANTAGONIST

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 BACK, M , DAHLEN, SE , DRAZEN, JM , EVANS, JF , SERHAN, CN , SHIMIZU, T , YOKOMIZO, T , ROVATI, GE , (2011) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXIV: LEUKOTRIENE RECEPTOR NOMENCLATURE, DISTRIBUTION, AND PATHOPHYSIOLOGICAL FUNCTIONS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 539-584 213 33% 37
2 THERON, AJ , STEEL, HC , TINTINGER, GR , GRAVETT, CM , ANDERSON, R , FELDMAN, C , (2014) CYSTEINYL LEUKOTRIENE RECEPTOR-1 ANTAGONISTS AS MODULATORS OF INNATE IMMUNE CELL FUNCTION.JOURNAL OF IMMUNOLOGY RESEARCH. VOL. . ISSUE . P. - 92 68% 11
3 CHAUHAN, BF , DUCHARMC, FM , (2012) ANTI-LEUKOTRIENE AGENTS COMPARED TO INHALED CORTICOSTEROIDS IN THE MANAGEMENT OF RECURRENT AND/OR CHRONIC ASTHMA IN ADULTS AND CHILDREN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - 139 43% 18
4 GARCIA-MARCOS, L , SCHUSTER, A , PEREZ-YARZA, EG , (2003) BENEFIT-RISK ASSESSMENT OF ANTILEUKOTRIENES IN THE MANAGEMENT OF ASTHMA.DRUG SAFETY. VOL. 26. ISSUE 7. P. 483-518 110 72% 29
5 CAPRA, V , THOMPSON, MD , SALA, A , COLE, DE , FOLCO, G , ROVATI, GE , (2007) CYSTEINYL-LEUKOTRIENES AND THEIR RECEPTORS IN ASTHMA AND OTHER INFLAMMATORY DISEASES: CRITICAL UPDATE AND EMERGING TRENDS.MEDICINAL RESEARCH REVIEWS. VOL. 27. ISSUE 4. P. 469 -527 149 36% 74
6 BUSSE, W , KRAFT, M , (2005) CYSTEINYL LEUKOTRIENES IN ALLERGIC INFLAMMATION - STRATEGIC TARGET FOR THERAPY.CHEST. VOL. 127. ISSUE 4. P. 1312 -1326 74 72% 84
7 RICCIONI, G , BUCCIARELLI, T , MANCINI, B , DI ILIO, C , D'ORAZIO, N , (2007) ANTILEUKOTRIENE DRUGS: CLINICAL APPLICATION, EFFECTIVENESS AND SAFETY.CURRENT MEDICINAL CHEMISTRY. VOL. 14. ISSUE 18. P. 1966-1977 100 46% 64
8 PATEL, N , PANDYA, K , GAJJAR, A , (2016) AN OVERVIEW OF DIFFERENT ANALYTICAL TECHNIQUES FOR LEUKOTRIENE ANTAGONISTS IN DIFFERENT MATRICES.CURRENT PHARMACEUTICAL ANALYSIS. VOL. 12. ISSUE 4. P. 275 -295 50 81% 0
9 CAPRA, V , AMBROSIO, M , RICCIONI, G , ROVATI, GE , (2006) CYSTEINYL-LEUKOTRIENE RECEPTOR ANTAGONISTS: PRESENT SITUATION AND FUTURE OPPORTUNITIES.CURRENT MEDICINAL CHEMISTRY. VOL. 13. ISSUE 26. P. 3213 -3226 107 43% 39
10 DEVILLIER, P , BACCARD, N , ADVENIER, C , (1999) LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART II: CLINICAL STUDIES WITH LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA.PHARMACOLOGICAL RESEARCH. VOL. 40. ISSUE 1. P. 15 -29 82 71% 20

Classes with closest relation at Level 1


Rank Class id link
1 3852 5 LIPOXYGENASE//LEUKOTRIENES//5 LIPOXYGENASE ACTIVATING PROTEIN
2 822 PROSTAGLANDINS//ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH//BAY U9773
3 8330 ASPIRIN EXACERBATED RESPIRATORY DISEASE//ASPIRIN INDUCED ASTHMA//ASPIRIN DESENSITIZATION
4 3415 FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL
5 11008 LATE PHASE RESPONSE//TYB 2285//LATE ASTHMATIC RESPONSE
6 2996 EXERCISE INDUCED ASTHMA//EXERCISE INDUCED BRONCHOCONSTRICTION//EXERCISE INDUCED BRONCHOSPASM
7 17640 12S HETE//LY293111//ZYFLAMEND
8 2577 INHALED CORTICOSTEROIDS//CICLESONIDE//FLUTICASONE PROPIONATE
9 19348 EOSINOPHIL CATIONIC PROTEIN//EOSINOPHIL PROTEIN X//EPX
10 4626 AIRWAY REMODELING//AIRWAY SMOOTH MUSCLE//ASTHMA

Go to start page